Followers | 34 |
Posts | 5999 |
Boards Moderated | 0 |
Alias Born | 03/07/2006 |
Wednesday, May 02, 2007 11:49:45 AM
TYLER, Texas, May 2, 2007 /PRNewswire-FirstCall via COMTEX/ -- BiogenericsLimited(Pink Sheets: BIGN) (GR: D9G) -- announces today that the Board of Directors has selected from among many suggested names by its Shareholders, thename -- Diversified Oil and Gas Holdings, Limited and has registered this name with the State of Nevada on behalf of the Company.In pursuing the Company's goals in selecting a name that is more indigenous to the Company's future operations, the Board felt this name was indicative of the Company's future business operations. The Company is processing paperwork necessary for the name change, new trading symbol and new cusip number at this time. Further details regarding the name change will be made when approvals are obtained. All previously announced business opportunities are continuing and the Company will update the market as these opportunities are concluded.
Website: http:/www.bignltd.comAbout Biogenerics Limited
Biogenerics is a diversified investment venture capital firm focused onexploitingand distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy Inc and Hydroslotter Corp.Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning ofthePrivate Securities Litigation Reform Act of 1995. Statements in this releasethatare forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or otherfactorswhich may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, orachievementsexpressed or implied by such forward- looking statements. Actual results could differ materially because of factors such as the effect of generaleconomicand market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existingproductsand services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues andincometo fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update anyforward-lookingstatement to conform the statement to actual results or changes in the company's expectations.SOURCE Biogenerics Limited
CONTACT: James Lancaster, CEO of Biogenerics Limited, Corporate
Inquiries, +1-903-581-4053, or Investor Relations, inquire at http://www.bignltd.com
URL: http://www.bignltd.com http://www.prnewswire.com
www.prnewswire.comCopyright (C) 2007 PR Newswire. All rights reserved
-0-KEYWORD: Texas
INDUSTRY KEYWORD: OILSUBJECT CODE: VEN
Source: Comtext Market News
Compliments of Scottrade.com
JMO - Do your own DD.
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM